These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27920819)

  • 1. Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver.
    El-Lakkany NM; Seif El-Din SH; Sabra AA; Hammam OA; Ebeid FA
    Res Pharm Sci; 2016 Oct; 11(5):374-382. PubMed ID: 27920819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in rats.
    Seif El-Din SH; El-Lakkany NM; El-Naggar AA; Hammam OA; Abd El-Latif HA; Ain-Shoka AA; Ebeid FA
    Res Pharm Sci; 2015; 10(4):275-87. PubMed ID: 26600855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and antioxidant actions of garlic and.or onion in non-alcoholic fatty liver disease (NAFLD) in rats.
    El-Din SH; Sabra AN; Hammam OA; Ebeid FA; El-Lakkany NM
    J Egypt Soc Parasitol; 2014 Aug; 44(2):295-308. PubMed ID: 25597144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-ACETYLCYSTEINE AND/OR URSODEOXYCHOLIC ACID ASSOCIATED WITH METFORMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL MULTICENTER RANDOMIZED CONTROLLED TRIAL.
    Oliveira CP; Cotrim HP; Stefano JT; Siqueira ACG; Salgado ALA; Parise ER
    Arq Gastroenterol; 2019 Aug; 56(2):184-190. PubMed ID: 31460584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
    Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
    J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.
    Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA
    Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Synergistic Protective Effect of γ-Oryzanol (OZ) and N-Acetylcysteine (NAC) against Experimentally Induced NAFLD in Rats Entails Hypoglycemic, Antioxidant, and PPARα Stimulatory Effects.
    Alwadani AH; Almasri SA; Aloud AA; Albadr NA; Alshammari GM; Yahya MA
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
    Ali MH; Messiha BA; Abdel-Latif HA
    Pharm Biol; 2016 Jul; 54(7):1198-208. PubMed ID: 26134756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis.
    de Oliveira CP; Stefano JT; de Siqueira ER; Silva LS; de Campos Mazo DF; Lima VM; Furuya CK; Mello ES; Souza FG; Rabello F; Santos TE; Nogueira MA; Caldwell SH; Alves VA; Carrilho FJ
    Hepatol Res; 2008; 38(2):159-65. PubMed ID: 18197877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
    Jiang W; Guo MH; Hai X
    World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease].
    Gao H; Xu L; Li D; Guang L; Deng W
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1661-4. PubMed ID: 24273273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin.
    Alfarisi HAH; Ibrahim MB; Mohamed ZBH; Azahari N; Hamdan AHB; Che Mohamad CA
    ScientificWorldJournal; 2020; 2020():4503253. PubMed ID: 33132768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis.
    Kumar A; Sharma A; Duseja A; Das A; Dhiman RK; Chawla YK; Kohli KK; Bhansali A
    J Clin Exp Hepatol; 2013 Mar; 3(1):12-8. PubMed ID: 25755466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats].
    Wang HY; Liang CM; Cui JW; Pan L; Hu H; Fang HJ
    Zhen Ci Yan Jiu; 2019 Mar; 44(3):189-94. PubMed ID: 30945501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.